OKYO Pharma Total Assets Growth & History (OKYO)
OKYO Pharma's total assets was $21.0M for fiscal 2026.
View full OKYO Pharma company overviewOKYO Pharma annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-03-31 | $21.0M | $17.3M | +470.42% |
| 2025 · Mar 31 | 2025-03-31 | $3.7M | $2.1M | +138.59% |
| 2024 | 2024-03-31 | $1.5M | −$3.7M | −70.38% |
| 2023 | 2023-03-31 | $5.2M | $903,327 | +21.00% |
| 2022 | 2022-03-31 | $4.3M | −$2.8M | −39.35% |
| 2021 | 2021-03-31 | $7.1M | — | — |
OKYO Pharma quarterly total assets
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q4 2026 | 2026-03-31 | $21.0M | $17.3M | +470.42% |
| Q2 2026 | 2025-09-30 | $4.6M | — | — |
| Q4 2025 | 2025-03-31 | $3.7M | $2.1M | +138.59% |
| Q4 2024 | 2024-03-31 | $1.5M | −$3.7M | −70.38% |
| Q4 2023 | 2023-03-31 | $5.2M | $903,327 | +21.00% |
| Q4 2022 | 2022-03-31 | $4.3M | −$2.8M | −39.35% |
| Q4 2021 | 2021-03-31 | $7.1M | — | — |
OKYO Pharma total assets trends
Over the last five fiscal years, OKYO Pharma's total assets increased from $7.1M to $21.0M, a change of $13.9M. The latest reported quarter, Q4 2026, shows $21.0M.
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review OKYO Pharma source filings ↗